复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床对照试验的Meta分析

孙红艳; 吕安坤

doi:10.13422/j.cnki.syfjx.2016110194

您当前的位置：

首页 >

文章列表页 >

复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床对照试验的Meta分析

数据挖掘 | 更新时间：2024-01-04

- 复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床对照试验的Meta分析
- Meta-analysis of Compound Xuanju Capsule Plus Antibiotics for Treating Patients with Chronic Prostatitis
- 中国实验方剂学杂志 2016年22卷第11期页码：194-197
- 作者机构：
- 作者简介：
- 基金信息：
  
  新疆维吾尔自治区自然科学基金项目(2014211C021)
- DOI：10.13422/j.cnki.syfjx.2016110194
  中图分类号： R697.33
- 纸质出版日期：2016
- 稿件说明：
移动端阅览
孙红艳, 吕安坤. 复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床对照试验的Meta分析[J]. 中国实验方剂学杂志, 2016,22(11):194-197.

SUN Hong-yan, LYU An-kun. Meta-analysis of Compound Xuanju Capsule Plus Antibiotics for Treating Patients with Chronic Prostatitis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(11): 194-197.
孙红艳, 吕安坤. 复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床对照试验的Meta分析[J]. 中国实验方剂学杂志, 2016,22(11):194-197. DOI： 10.13422/j.cnki.syfjx.2016110194.

SUN Hong-yan, LYU An-kun. Meta-analysis of Compound Xuanju Capsule Plus Antibiotics for Treating Patients with Chronic Prostatitis[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(11): 194-197. DOI： 10.13422/j.cnki.syfjx.2016110194.

摘要

目的: 系统评价复方玄驹胶囊治疗慢性前列腺炎的临床疗效。方法: 计算机检索CNKI中国知网(总库)

维普数据库

PubMed

Cochrane图书馆。由2名评价者独立对纳入文献进行信息录入、质量评价。采用RevMan 5.2软件进行Meta分析。结果: 共纳入10个临床随机对照试验

包括1 506例患者。结果显示

复方玄驹胶囊联合抗生素与抗生素组治疗慢性前列腺炎临床疗效相比有统计学意义[OR=2.86

95%CI(2.28

3.58)

P < 0.000 01]。结论: 现有证据表明

复方玄驹胶囊联合抗生素治疗慢性前列腺炎临床疗效优于单用抗生素组。但上述结论尚需大样本高质量临床试验加以证实。

Abstract

Objective: To systemically assess the clinical efficacy of compound Xuanju capsule for chronic prostatitis. Method: We systemically searched China National Knowledge Infrastructure (CNKI)

VIP Database

PubMed and Cochrane Library for clinical trials. The information was recorded and the methodological quality of the included trials was assessed by two reviewers independently

and the valid data was analyzed by RevMan 5.2 software. Result: The 10 randomized control trials involving 1 506 patients were included in the study. Meta-analysis showed that there was statistically significant difference in clinical efficacy between compound Xuanju capsule plus antibiotics group and the antibiotics alone group in the treatment of chronic prostatitis [OR=2.86

95%CI (2.28

3.58)

P < 0.000 01]. Conclusion: The current evidence showed that

the compound Xuanju capsule combined with antibiotics in the treatment of chronic prostatitis was more effective than antibiotics alone. However

large and high-quality clinical trials are still required for verification.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

和血明目片治疗糖尿病视网膜病变和视网膜静脉阻塞的系统评价及Meta分析

基于睾丸支持细胞结构功能探讨中药改善生精功能的动物实验系统评价

蒲参胶囊治疗高脂血症有效性和安全性的系统评价与Meta分析

中药方剂内服治疗耐药细菌性肺炎的系统评价与Meta分析

半夏泻心汤及其加减方治疗溃疡性结肠炎疗效和安全性的系统评价